DYN Stock Analysis: Buy, Sell, or Hold?
DYN - Dyne Therapeutics, Inc. Common Stock
$18.84
0.74 (4.09%)
▲
5d:
+1.56%
30d:
+23.7%
90d:
-3.68%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
DYN is down 8.6% this week, but smart money is accumulating calls. Top strike: $15 2026-04-17 with 3 OI. Call ratio: 62% View Scanner →
Strength: 5.6/10
Get Alerted When DYN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DYN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DYN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DYN is currently trading at $18.84, which is considered extended relative to its 30-day fair value range of $15.82 to $18.75.
Technical Outlook: Technically, DYN is in a downtrend. The price is approaching resistance at $19.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.19 (+111.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DYN is in a downtrend. The price is approaching resistance at $19.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.19 (+111.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$15.82 -
$18.75
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
56.3%
Protect Your Profits
Holding DYN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 111.0% below Wall St target ($38.19)
Fair Price Analysis
30-Day Fair Range
$15.82 -
$18.75
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$16.87
Resistance Level
$19.29
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.97
Wall Street Target
$38.19
(+111.0%)
Share & Embed Analysis
Last updated: April 02, 2026 4:51 PM ET
Data refreshes hourly during market hours. Next update: 5:51 PM
Data refreshes hourly during market hours. Next update: 5:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brian S Posner
BUY
3000 shares
2026-03-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
Advanced DYN Option Strategies
Professional options setups generated by AI based on today's DYN price and gamma walls.